Celladon Corporation (CLDN) was a big mover last session, as its shares rose nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend of the company since April 1, as the stock is now trading above the volatile price range of $9.21 to $11.48.
In the last 30-day frame, the company witnessed two negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Celladon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. (ANIP), ZIOPHARM Oncology, Inc. (ZIOP) and Alexion Pharmaceuticals, Inc. (ALXN). While ANI Pharmaceuticals and ZIOPHARM Oncology sport a Zacks Rank #1 (Strong Buy), ALexion carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CELLADON CORP (CLDN): Free Stock Analysis Report
ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report
ZIOPHARM ONCOLOGY INC (ZIOP): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies